{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:05:47Z","timestamp":1774677947162,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12149-025-02021-y","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:41:06Z","timestamp":1739454066000},"page":"476-505","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinicopathologic and metabolic variables from 18F-FDG PET\/CT in the prediction of recurrence pattern in stage I\u2013III non-small cell lung cancer after curative surgery"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3531-9180","authenticated-orcid":false,"given":"G. A.","family":"Jimenez Londo\u00f1o","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00e9rez-Beteta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Amo-Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Honguero-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. M.","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lucas Lucas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Garc\u00eda Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2021_CR1","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.3390\/jcm9082473","volume":"9","author":"R Shimizu","year":"2020","unstructured":"Shimizu R, Kinoshita T, Sasaki N, Uematsu M, Sugita Y, Shima T, et al. Clinicopathological factors related to recurrence patterns of resected non-small cell lung cancer. J Clin Med. 2020;9:2473.","journal-title":"J Clin Med"},{"key":"2021_CR2","doi-asserted-by":"publisher","first-page":"djv059","DOI":"10.1093\/jnci\/djv059","volume":"107","author":"D Consonni","year":"2015","unstructured":"Consonni D, Pierobon M, Gail MH, Rubagotti M, Rotunno M, Goldstein A, et al. Lung cancer prognosis before and after recurrence in a population-based setting. J Natl Cancer Inst. 2015;107:djv059.","journal-title":"J Natl Cancer Inst"},{"key":"2021_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.6004\/jnccn.2022.0025","volume":"20","author":"DS Ettinger","year":"2022","unstructured":"Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, et al. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:497\u2013530.","journal-title":"J Natl Compr Canc Netw"},{"key":"2021_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1200\/JCO.19.02748","volume":"38","author":"BJ Schneider","year":"2020","unstructured":"Schneider BJ, Ismaila N, Aerts J, Chiles C, Daly ME, Detterbeck FC, et al. Lung cancer surveillance after definitive curative-intent therapy: ASCO guideline. J Clin Oncol. 2020;38:753\u201366.","journal-title":"J Clin Oncol"},{"key":"2021_CR5","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/j.cllc.2015.12.013","volume":"17","author":"DA Dziedzic","year":"2016","unstructured":"Dziedzic DA, Rudzinski P, Langfort R, Orlowski T. Risk factors for local and distant recurrence after surgical treatment in patients with non\u2013small-cell lung cancer. Clin Lung Cancer. 2016;17:e157\u201367.","journal-title":"Clin Lung Cancer"},{"key":"2021_CR6","doi-asserted-by":"publisher","first-page":"58261","DOI":"10.18632\/oncotarget.11338","volume":"7","author":"JJ Hung","year":"2016","unstructured":"Hung JJ, Jeng WJ, Wu YC, Chou TY, Hsu WH. Factors predicting organ-specific distant metastasis in patients with completely resected lung adenocarcinoma. Oncotarget. 2016;7:58261\u201373.","journal-title":"Oncotarget"},{"key":"2021_CR7","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/app10051718","volume":"10","author":"F Bianconi","year":"2020","unstructured":"Bianconi F, Palumbo I, Spanu A, Nuvoli S, Fravolini ML, Palumbo B. PET\/CT radiomics in lung cancer: an overview. Appl Sci. 2020;10:1718.","journal-title":"Appl Sci"},{"key":"2021_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymeth.2020.05.023","volume":"188","author":"R Manafi-Farid","year":"2021","unstructured":"Manafi-Farid R, Karamzade-Ziarati N, Vali R, Mottaghy FM, Beheshti M. 2-[18F]FDG PET\/CT radiomics in lung cancer: an overview of the technical aspect and its emerging role in management of the disease. Methods. 2021;188:84\u201397.","journal-title":"Methods"},{"key":"2021_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s13139-017-0500-y","volume":"52","author":"JW Lee","year":"2018","unstructured":"Lee JW, Lee SM. Radiomics in oncological PET\/CT: clinical applications. Nucl Med Mol Imag. 2018;52:170\u201389.","journal-title":"Nucl Med Mol Imag"},{"key":"2021_CR10","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.semnuclmed.2022.04.007","volume":"52","author":"RJ Hicks","year":"2022","unstructured":"Hicks RJ. The value of the standardized uptake value (SUV) and metabolic tumor volume (MTV) in lung cancer. Semin Nucl Med. 2022;52:734\u201344.","journal-title":"Semin Nucl Med"},{"key":"2021_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/JTO.0b013e31815e6d6b","volume":"3","author":"T Berghmans","year":"2008","unstructured":"Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, et al. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European lung cancer working party for the IASLC lung cancer staging project. J Thorac Oncol. 2008;3:6\u201312.","journal-title":"J Thorac Oncol"},{"key":"2021_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00259-017-3837-7","volume":"45","author":"M Kirienko","year":"2018","unstructured":"Kirienko M, Cozzi L, Antunovic L, Lozza L, Fogliata A, Voulaz E, et al. Prediction of disease-free survival by the PET\/CT radiomic signature in non-small cell lung cancer patients undergoing surgery. Eur J Nucl Med Mol Imag. 2018;45:207\u201317.","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"2021_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0022-5223(19)40289-4","volume":"70","author":"N Martini","year":"1975","unstructured":"Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606\u201312.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2021_CR14","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s00330-021-08523-3","volume":"32","author":"GA Jim\u00e9nez Londo\u00f1o","year":"2022","unstructured":"Jim\u00e9nez Londo\u00f1o GA, Garc\u00eda Vicente AM, Bosque JJ, Amo-Salas M, P\u00e9rez-Beteta J, Honguero-Martinez AF, et al. SUVmax to tumor perimeter distance: a robust radiomics prognostic biomarker in resectable non-small cell lung cancer patients. Eur Radiol. 2022;32:3889\u2013902.","journal-title":"Eur Radiol"},{"key":"2021_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1148\/radiol.2018171051","volume":"288","author":"J P\u00e9rez-Beteta","year":"2018","unstructured":"P\u00e9rez-Beteta J, Molina-Garc\u00eda D, Ortiz-Alhambra JA, Fern\u00e1ndez-Romero A, Luque B, Arregui E, et al. Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology. 2018;288:218\u201325.","journal-title":"Radiology"},{"key":"2021_CR16","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1097\/RLU.0000000000003166","volume":"45","author":"GA Jim\u00e9nez Londo\u00f1o","year":"2020","unstructured":"Jim\u00e9nez Londo\u00f1o GA, P\u00e9rez-Beteta J, Bosque JJ, Honguero-Martinez AF, Garc\u00eda Vicente AM. Segmentation in non-small cell lung tumors using 18F-FDG PET\/CT: tips and rules. Clin Nucl Med. 2020;45:e477\u201382.","journal-title":"Clin Nucl Med"},{"key":"2021_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178843","volume":"12","author":"D Molina","year":"2017","unstructured":"Molina D, P\u00e9rez-Beteta J, Mart\u00ednez-Gonz\u00e1lez A, Martino J, Velasquez C, Arana E, et al. Lack of robustness of textural measures obtained from 3D brain tumor MRIs impose a need for standardization. PLoS ONE. 2017;12: e0178843.","journal-title":"PLoS ONE"},{"key":"2021_CR18","doi-asserted-by":"publisher","first-page":"20160242","DOI":"10.1259\/bjr.20160242","volume":"89","author":"D Molina","year":"2016","unstructured":"Molina D, P\u00e9rez-Beteta J, Luque B, Arregui E, Calvo M, Borr\u00e1s JM, et al. Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol. 2016;89:20160242.","journal-title":"Br J Radiol"},{"key":"2021_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s12149-017-1203-2","volume":"31","author":"AM Garcia-Vicente","year":"2017","unstructured":"Garcia-Vicente AM, Molina D, P\u00e9rez-Beteta J, Amo-Salas M, Mart\u00ednez-Gonz\u00e1lez A, Bueno G, et al. Textural features and SUV-based variables assessed by dual time point 18F-FDG PET\/CT in locally advanced breast cancer. Ann Nucl Med. 2017;31:726\u201335.","journal-title":"Ann Nucl Med"},{"key":"2021_CR20","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s11307-016-1034-x","volume":"19","author":"AM Garcia-Vicente","year":"2017","unstructured":"Garcia-Vicente AM, P\u00e9rez-Beteta J, P\u00e9rez-Garc\u00eda VM, Molina D, Jim\u00e9nez-Londo\u00f1o GA, Soriano-Castrej\u00f3n A, et al. Metabolic tumor burden assessed by dual time point [18F]FDG PET\/CT in locally advanced breast cancer: relation with tumor biology. Mol Imag Biol. 2017;19:636\u201344.","journal-title":"Mol Imag Biol"},{"key":"2021_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12149-018-1253-0","volume":"32","author":"D Molina-Garc\u00eda","year":"2018","unstructured":"Molina-Garc\u00eda D, Garc\u00eda-Vicente AM, P\u00e9rez-Beteta J, Amo-Salas M, Mart\u00ednez-Gonz\u00e1lez A, Tello-Gal\u00e1n MJ, et al. Intratumoral heterogeneity in 18F-FDG PET\/CT by textural analysis in breast cancer as a predictive and prognostic subrogate. Ann Nucl Med. 2018;32:379\u201388.","journal-title":"Ann Nucl Med"},{"key":"2021_CR22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2018110118","volume":"118","author":"J Jim\u00e9nez-S\u00e1nchez","year":"2021","unstructured":"Jim\u00e9nez-S\u00e1nchez J, Bosque JJ, Jim\u00e9nez Londo\u00f1o GA, Molina-Garc\u00eda D, Mart\u00ednez \u00c1, P\u00e9rez-Beteta J, et al. Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers. Proc Natl Acad Sci USA. 2021;118: e2018110118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/ejcts\/ezab442","volume":"61","author":"T Isaka","year":"2022","unstructured":"Isaka T, Ito H, Nakayama H, Yokose T, Saito H, Masuda M. Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer. Eur J Cardiothorac Surg. 2022;61:778\u201386.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2021_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","volume":"83","author":"H Sugimura","year":"2007","unstructured":"Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83:409\u201318.","journal-title":"Ann Thorac Surg"},{"key":"2021_CR25","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1378\/chest.12-1717","volume":"143","author":"Y Shimada","year":"2013","unstructured":"Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M, et al. Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest. 2013;143:1626\u201334.","journal-title":"Chest"},{"key":"2021_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.33160\/yam.2017.12.001","volume":"60","author":"Y Kubouchi","year":"2017","unstructured":"Kubouchi Y, Kidokoro Y, Ohno T, Yurugi Y, Wakahara M, Haruki T, et al. Prognostic factors for post recurrence survival in resected pathological stage I non-small cell lung cancer. Yonago Acta Med. 2017;60:213\u20139.","journal-title":"Yonago Acta Med"},{"key":"2021_CR27","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12885-020-6621-1","volume":"20","author":"C Wang","year":"2020","unstructured":"Wang C, Wu Y, Shao J, Liu D, Li W. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer. BMC Cancer. 2020;20:150.","journal-title":"BMC Cancer"},{"key":"2021_CR28","first-page":"204","volume":"7","author":"I Yoshino","year":"2001","unstructured":"Yoshino I, Yohena T, Kitajima M, Ushijima C, Nishioka K, Ichinose Y, et al. Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann Thorac Cardiovasc Surg. 2001;7:204\u20139.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2021_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.resinv.2012.08.007","volume":"50","author":"T Baba","year":"2012","unstructured":"Baba T, Uramoto H, Takenaka M, Chikaishi Y, Oka S, Shigematsu Y, et al. Prognostic factors before and after recurrence of resected non-small cell lung cancer. Respir Investig. 2012;50:151\u20136.","journal-title":"Respir Investig"},{"key":"2021_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/PL00012065","volume":"5","author":"M Sakurai","year":"2000","unstructured":"Sakurai M, Hayashi I, Nakagawa K, Sakurai M, Hayashi I, Nakagawa K. Prognostic factors in post-surgical recurrence of lung cancer. Int J Clin Oncol. 2000;5:367\u201371.","journal-title":"Int J Clin Oncol"},{"key":"2021_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.athoracsur.2014.05.061","volume":"98","author":"A Kiankhooy","year":"2014","unstructured":"Kiankhooy A, Taylor MD, Lapar DJ, Isbell JM, Lau CL, Kozower BD, et al. Predictors of early recurrence for node-negative t1 to T2B non-small cell lung cancer. Ann Thorac Surg. 2014;98:1175\u201383.","journal-title":"Ann Thorac Surg"},{"key":"2021_CR32","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.21873\/anticanres.14989","volume":"41","author":"T Tsukioka","year":"2021","unstructured":"Tsukioka T, Izumi N, Komatsu H, Inoue H, Miyamoto H, Ito R, et al. Tumor size and N2 lymph node metastasis are significant risk factors for early recurrence in completely resected centrally located primary lung cancer patients. Anticancer Res. 2021;41:2165\u20139.","journal-title":"Anticancer Res"},{"key":"2021_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11748-006-0082-6","volume":"55","author":"T Tsukioka","year":"2007","unstructured":"Tsukioka T, Nishiyama N, Iwata T, Izumi N, Mizuguchi S, Morita R, et al. Early recurrence of completely resected N2-positive non-small-cell lung cancer. Gen Thorac Cardiovasc Surg. 2007;55:113\u20138.","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"2021_CR34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1007\/s11307-019-01336-3","volume":"21","author":"F Bianconi","year":"2019","unstructured":"Bianconi F, Palumbo I, Fravolini ML, Chiari R, Minestrini M, Brunese L, et al. Texture analysis on [18 F] FDG PET\/CT in non-small-cell lung cancer: correlations between PET features, CT features, and histological types. Mol Imaging Biol. 2019;21:1200\u20139.","journal-title":"Mol Imaging Biol"},{"key":"2021_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.5761\/atcs.oa.11.01660","volume":"17","author":"T Sakai","year":"2011","unstructured":"Sakai T, Tsushima T, Kimura D, Hatanaka R, Yamada Y, Fukuda I. A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma. Ann Thorac Cardiovasc Surg. 2011;17:539\u201343.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2021_CR36","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/MNM.0000000000001646","volume":"44","author":"SB Park","year":"2023","unstructured":"Park SB, Kim KU, Park YW, Hwang JH, Lim CH. Application of 18F-fluorodeoxyglucose PET\/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy. Nucl Med Commun. 2023;44:161\u20138.","journal-title":"Nucl Med Commun"},{"key":"2021_CR37","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2967\/jnumed.123.266331","volume":"65","author":"N Hovhannisyan-Baghdasarian","year":"2024","unstructured":"Hovhannisyan-Baghdasarian N, Luporsi M, Captier N, Nioche C, Cuplov V, Woff E, et al. Promising candidate prognostic biomarkers in [18F]FDG PET images: evaluation in independent cohorts of non-small cell lung cancer patients. J Nucl Med. 2024;65:635\u201342.","journal-title":"J Nucl Med"},{"key":"2021_CR38","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jso.21750","volume":"102","author":"T Yano","year":"2010","unstructured":"Yano T, Haro A, Yoshida T, Morodomi Y, Ito K, Shikada Y, et al. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer. J Surg Oncol. 2010;102:852\u20135.","journal-title":"J Surg Oncol"},{"key":"2021_CR39","first-page":"1420","volume":"6","author":"C Park","year":"2014","unstructured":"Park C, Lee IJ, Jang SH, Lee JW. Factors affecting tumor recurrence after curative surgery for NSCLC: Impacts of lymphovascular invasion on early tumor recurrence. J Thorac Dis. 2014;6:1420\u20138.","journal-title":"J Thorac Dis"},{"key":"2021_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/ejcts\/ezv249","volume":"49","author":"T Hishida","year":"2015","unstructured":"Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival. Eur J Cardiothorac Surg. 2015;49:847\u201353.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2021_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/thx.2008.110825","volume":"65","author":"JJ Hung","year":"2010","unstructured":"Hung JJ, Jeng WJ, Hsu WH, Wu KJ, Chou TY, Hsieh CC, et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax. 2010;65:241\u20135.","journal-title":"Thorax"},{"key":"2021_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/JTO.0b013e3181ff9b45","volume":"6","author":"S Wei","year":"2011","unstructured":"Wei S, Asamura H, Kawachi R, Sakurai H, Watanabe SI. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol. 2011;6:310\u20138.","journal-title":"J Thorac Oncol"},{"key":"2021_CR43","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/diagnostics11020189","volume":"11","author":"O Manabe","year":"2021","unstructured":"Manabe O, Yamaguchi S, Hirata K, Kobayashi K, Kobayashi H, Terasaka S, et al. Preoperative texture analysis using 11C-methionine positron emission tomography predicts survival after surgery for glioma. Diagnostics. 2021;11:189.","journal-title":"Diagnostics"},{"key":"2021_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094017","volume":"9","author":"M Soussan","year":"2014","unstructured":"Soussan M, Orlhac F, Boubaya M, Zelek L, Ziol M, Eder V, et al. Relationship between tumor heterogeneity measured on FDG-PET\/CT and pathological prognostic factors in invasive breast cancer. PLoS ONE. 2014;9: e94017.","journal-title":"PLoS ONE"},{"key":"2021_CR45","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JTO.0b013e31819c7bc9","volume":"4","author":"I Sekine","year":"2009","unstructured":"Sekine I, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Comparative chemotherapeutic efficacy in non-small cell lung cancer patients with postoperative recurrence and stage IV disease. J Thorac Oncol. 2009;4:518\u201321.","journal-title":"J Thorac Oncol"},{"key":"2021_CR46","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/COC.0000000000000513","volume":"42","author":"S Moore","year":"2019","unstructured":"Moore S, Leung B, Wu J, Ho C. Survival implications of de novo versus recurrent metastatic non-small cell lung cancer. Am J Clin Oncol. 2019;42:292\u20137.","journal-title":"Am J Clin Oncol"},{"key":"2021_CR47","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/JTO.0b013e31824cbad8","volume":"7","author":"JJ Hung","year":"2012","unstructured":"Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol. 2012;7:1115\u201323.","journal-title":"J Thorac Oncol"},{"key":"2021_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","volume":"33","author":"W Liang","year":"2015","unstructured":"Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33:861\u20139.","journal-title":"J Clin Oncol"},{"key":"2021_CR49","doi-asserted-by":"publisher","first-page":"799","DOI":"10.52547\/ijrr.18.4.799","volume":"18","author":"F Demir","year":"2020","unstructured":"Demir F, Yanarate\u015f A. Prognostic value of various metabolic parameters on pre-treatment 18F-FDG PET\/CT in patients with stage I-III non-small cell lung cancer. Int J Radiat Res. 2020;18:799\u2013807.","journal-title":"Int J Radiat Res"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-025-02021-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-025-02021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T09:02:46Z","timestamp":1745312566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-025-02021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2021"],"URL":"https:\/\/doi.org\/10.1007\/s12149-025-02021-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5153703\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this retrospective study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval was granted by the Institutional Ethics Investigation Committee of Hospital General Universitario de Ciudad Real (institutional review board approval number 10\/2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}